International Society of Cannabis Nexus Update: Zimbabwe Cabinet cut cannabis fees by up to 90 percent / South Africa Department of Trade, Industry and Competition lists a Hemp and Cannabis Inward Buying Mission

One of the four decisions below expires on Friday. The other three are about reading a cheaper door correctly before you walk through it.

The Department of Trade, Industry and Competition lists a Hemp and Cannabis Inward Buying Mission for 22 to 24 October 2026, with ten hosted buyer places, a named EMIA contact and an application due date of 21 August 2026. The same list states that details are subject to change and that full application details and forms are published with each recruitment advertisement, so the mailbox on the list is the working entry point today.

Source: the dtic, Group Mission List 2026/7 →

A state hosted buying mission is the cheapest introduction a foreign buyer will get to a market this size, and it is the seller side that South Africa is subsidising. The constraint sits one level down. Private adult use is decriminalised, while commercial trade runs through licensed medicinal channels and industrial hemp, with hemp defined at no more than 2 percent THC since December 2025. The product you can actually contract for is SAHPRA regulated medicinal supply, or hemp fibre and seed. The export capability behind it is proven but small: South African flower reached Germany at roughly 3.7 tonnes in 2025 against a 201 tonne national import total, one of the sharpest growth rates of any origin from a low base.

Context: South African cannabis and hemp compliance position, 2026 →  ·  German import origins →

Cabinet approved reductions of up to 90 percent under the residual phase of its Mop-Up Review, announced by Finance Minister Mthuli Ncube at a post-Cabinet briefing. Read the lines separately, because the headline number is the smallest one. The MCAZ application processing fee falls from US$10,000 to US$1,000, the five-year medicinal cannabis licence from US$50,000 to US$15,000, renewal from US$50,000 to US$7,500, the research fee from US$5,000 to US$1,000 and inspection from US$2,500 to US$400. Industrial hemp registration drops from US$500 to US$250 and annual farmer registration from US$200 to US$50. ISC read: your first-cycle cost is closer to US$16,000 than to US$1,000, and this is still a Cabinet announcement with no implementing statutory instrument sighted, so confirm the gazetted schedule with MCAZ before filing. The regime runs on Statutory Instrument 62 of 2018 and stays export oriented, so the binding constraint is your offtake and your GACP evidence rather than the fee. Separately, MCAZ has readvertised works on its own cannabis laboratory, which shows where the authority is spending.

Inside NEXUS: members received the fee lines that matter per licence class, the verification route into MCAZ, and the supplier registration condition attached to the laboratory works notice.

Source: NewZimbabwe →  ·  Corroboration: NewsDay →

The Council of Ministers approved a concession agreement with InipasvalleyRw for a High-Value Therapeutic Crops project on 24 July. Rwanda has permitted cultivation, processing and export for medical and therapeutic use since 2021. Official confirmation that this concession covers cannabis has not been published, the Rwanda Development Board did not answer the question when The New Times put it directly, and the therapeutic crop category also covers plants such as artemisia and moringa. The precedent matters more than the announcement: the country’s first licensed cannabis operator, licensed in 2024, says its project stalled over funding it expected from government and unresolved land title. ISC read: watch, and keep the institutional map current. A single concession holder in a small controlled market changes who a foreign entrant needs on side, and the last holder’s experience is the better guide to execution risk than the Cabinet minute.

Inside NEXUS: members received the confirmation trigger to watch for, and the institutions that will publish it first.

Source: AllAfrica →

Cannabis Licensing Authority chair Dr Nadeen Spence said publicly that Jamaica will eventually have to reopen to foreign ganja if it wants export growth, while CEO Farrah Blake said there is no case for importing while local production rises. Imports have been suspended since the 2023 licence backlash. In the same fortnight the CLA cut its transitional cultivator permit fee from US$3,000 to US$150 and started islandwide roadshows to bring legacy farmers in. ISC read: hold any inbound Jamaica supply plan. Every new legacy grower added to the regulated base weakens the domestic argument for imports, so the reopening moves further out, not closer. The live commercial question in Jamaica is service, offtake and route to export, not selling flower into it.

Inside NEXUS: members received the import licence basis, the reopening signals worth tracking, and where a foreign supplier can still participate under the current position.

Source: Jamaica Observer, import position →  ·  Permit fee cut →

1 September · Cayman Islands. Submissions on the Law Reform Commission’s cannabis discussion paper close. The paper leans toward decriminalising possession without opening retail supply, so the framing of the supply question is still being set. Consultation notice →

7 September, then early October · Israel. Exporter questionnaires are due 7 September in the investigation reopened on 5 August and covered here last week. The date that would actually move sourcing comes next: 60 days after the reopening, the Commissioner can impose a provisional duty on his own authority, without the ministerial route that stopped the last attempt. Verify importer demand now, before that window rather than after. Source: StratCann →  ·  Procedural route →

No date, real consequence · India. CDSCO approved an oral synthetic CBD medicine for mild to moderate anxiety, prescribed by psychiatrists. In the largest Global South pharmaceutical market, the first approved route is synthetic and pharma controlled, which is a substitution signal for anyone building a plant derived India thesis. Source: HempToday →

Watch the interview, 1h03 →

Shanika Roberts-Odle, chief executive of the Barbados Medicinal Cannabis Licensing Authority, describes a framework still in its first stage while cultivation, processing and product availability advance, two further medicinal centres move toward opening, and GrowerIQ has been selected for seed-to-sale tracking. Asked what is actually holding the sector back, she points at banking rather than regulation: local banks will not serve cannabis businesses. ISC read: if Barbados is on your list, settle the payment and banking route before the licence route. A framework that works and a bank that will receive your money are two separate approvals, and only one of them is published.